Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma (International Journal of Hematology, (2019), 109, 1, (107-114), 10.1007/s12185-018-2543-y)
on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT)
Research output: Contribution to journal › Comment/debate › peer-review
Fingerprint
Dive into the research topics of 'Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma (International Journal of Hematology, (2019), 109, 1, (107-114), 10.1007/s12185-018-2543-y)'. Together they form a unique fingerprint.